Protection and antibody response caused by turkey herpesvirus vector newcastle disease vaccine

Avian Diseases

Volumn 57, Issue 4, 2013, Pages 750-755

  Esaki, Motoyuki ^a,b   Godoy, Alecia ^a   Rosenberger, Jack K ^c   Rosenberger, Sandra C ^c   Gardin, Yannick ^d   Yasuda, Atsushi ^b   Dorsey, Kristi Moore ^a  

^a Ceva Animal Health LLC   (United States)

^b Ceva Animal Health (Ceva Japan)   (Japan)

^c Aviserve LLC   (United States)

^d CEVA SANTÉ ANIMALE   (France)

Author keywords

immunity; Newcastle disease; protection; turkey herpesvirus; vector vaccine

Indexed keywords

LIVE VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

AGE; ANIMAL; ANIMAL DISEASE; ANTIBODY PRODUCTION; ARTICLE; BIRD DISEASE; BLOOD; CHICK EMBRYO; CHICKEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GERMFREE ANIMAL; HEMAGGLUTINATION INHIBITION TEST; HUMORAL IMMUNITY; IMMUNOLOGY; MAREK DISEASE; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; TRACHEA; VIROLOGY;

AGE FACTORS; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHICK EMBRYO; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY, HUMORAL; MAREK DISEASE; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; TRACHEA; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL FUSION PROTEINS;

EID: 84891603468     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/10540-032613-Reg.1     Document Type: Article

References (28)

1. Alexander, D. J., and D. A. Senne. Newcastle disease. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Iowa State University Press, Ames, IA. pp. 75-100. 2008.
2. Ballagi-Pordany, A., E. Wehmann, J. Herczeg, S. Belák, and B. Lomniczi. Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch. Virol. 141:243-261. 1996.
3. Boursnell, M. E., P. F. Green, J. I. Campbell, A. Deuter, R. W. Peters, F. M. Tomley, A. C. Samson, P. Chambers, P. T. Emmerson, and M. M. Binns. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J. Gen. Virol. 71:621-628. 1990.
4. Calnek, B. W., W. R. Shek, and K. A. Schat. Latent infections with Marek's disease virus and turkey herpesvirus. J. Natl. Cancer Inst. 66:585-590. 1981.
5. Dortmans, J. C., B. P. Peeters, and G. Koch. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application Vet. Microbiol. 160:17-22. 2012.
6. Esaki, M., L. Noland, T. Eddins, A. Godoy, S. Saeki, S. Saitoh, A. Yasuda, and K. M. Dorsey. Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens. Avian Dis. 57:192-198. 2013.
7. Heller, E. D., and K. A. Schat. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol. 16:51-60. 1987.
8. Hu, S., H. Ma, Y. Wu, W. Liu, X. Wang, Y. Liu, and X. Liu. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27:904-910. 2009.
9. Kitamoto, N., K. Ikuta, S. Kato, and S. Yamaguchi. Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against a Marek's disease lymphoma cell line (MSB-1). Biken J. 22:11-20. 1979.
10. Kumar, S., B. Nayak, P. L. Collins, and S. K. Samal. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J. Virol. 85:6521-6534. 2011.
11. Meulemans, G., M. Gonze, M. C. Carlier, P. Petit, A. Burny, and L. Long. Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease. Avian Pathol. 15:761-768. 1986.
12. Miller, P. J., C. Estevez, Q. Yu, D. L. Suarez, and D. J. King. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis. 53:39-49. 2009.
13. Miller, P. J., D. J. King, C. L. Afonso, and D. L. Suarez. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238-7246. 2007.
14. Morgan, R. W., J. Gelb Jr, C. R. Pope, and P. J. Sondermeijer. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Dis. 37:1032-1040. 1993.
15. Nagai, Y., H. D. Klenk, and R. Rott. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72:494-508. 1976.
16. Nagai, Y., T. Yoshida, M. Hamaguchi, H. Naruse, M. Iinuma, K. Maeno, and T. Matsumoto. The pathogenicity of Newcastle disease virus isolated from migrating and domestic ducks and the susceptibility of the viral glycoproteins to proteolytic cleavage. Microbiol. Immunol. 24: 173-177. 1980.
17. Office International des Epizootics [OIE]. Newcastle disease. In: Manual of diagnostic tests and vaccines for terrestrial animals 2012, Chapter 2.3.14. OIE, Paris, France. pp. 576-589. 2012.
18. Palya, V., I. Kiss, T. Tatár-Kis, T. Mató, B. Felföldi, and Y. Gardin. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Avian Dis. 56:282-287. 2012.
19. Rauw, F., Y. Gardin, V. Palya, S. Anbari, S. Lemaire, M. Boschmans, T. van den Berg, and B. Lambrecht. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 28:823-833. 2010.
20. Reddy, S. K., J. M. Sharma, J. Ahmad, D. N. Reddy, J. K. McMillen, S. M. Cook, M. A. Wild, and R. D. Schwartz. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14:469-477. 1996.
21. Schat, K. A., and V. Nair. Marek's disease. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Iowa State University Press, Ames, IA. pp. 452-514. 2008.
22. Senne, D. A., D. J. King, and D. R. Kapczynski. Control of Newcastle disease by vaccination. Dev. Biol. (Basel) 119:165-170. 2004.
23. Sonoda, K., M. Sakaguchi, H. Okamura, K. Yokogawa, E. Tokunaga, S. Tokiyoshi, Y. Kawaguchi, and K. Hirai. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies. J. Virol. 74:3217-3226. 2000.
24. Taylor, J., C. Edbauer, A. Rey-Senelonge, J. F. Bouquet, E. Norton, S. Goebel, P. Desmettre, and E. Paoletti. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64:1441-1450. 1990.
25. Tsukamoto, K., S. Saito, S. Saeki, T. Sato, N. Tanimura, T. Isobe, M. Mase, T. Imada, N. Yuasa, and S. Yamaguchi. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 76:5637-5645. 2002.
26. van Boven, M., A. Bouma, T. H. Fabri, E. Katsma, L. Hartog, and G. Koch. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol. 37:1-5. 2008.
27. Witter, R. L., and L. Offenbecker. Duration of vaccinal immunity against Marek's disease. Avian Dis. 22:396-407. 1978.
28. Yamane, N., T. Odagiri, J. Arikawa, M. Morita, N. Sukeno, and N. Ishida. Isolation of orthomyxoviruses from migrating and domestic ducks in northern Japan in 1976-1977. Jpn. J. Med. Sci. Biol. 31:407-415. 1978.